A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA

Clinical trial NCT03000439 · COMPLETED

Trial details

NCT number: NCT03000439
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arthritis Juvenile Idiopathic

Start date: 2018-05-10
Primary completion: 2024-03-27
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.